image goes here
Regulatory Fine Points: Exploring 21 CFR Part 11 Validation
FDA is placing an increased emphasis on compliance with 21 CFR Part 11. Institutions, health systems, IRB offices, private research clinics, and developers—to name a few—need to understand the basics of the regulation and how to comply.
In this session, James Riddle, Stuart Cotter, and Shannon Roznoski of Advarra will review how the partnerships between software vendors, research institutions, and other stakeholders work to support regulatory guidelines. They will discuss in detail which parts each party is responsible for when building, implementing, and maintaining clinical trials software in a government-regulated process.
Learning Objectives:
- Understand basic requirements of 21 CFR Part 11 as it relates to computer systems commonly used by research institutions
- Identify which systems at your institution may be subject to Part 11
- Determine the basic actions, policies, and procedures that need to be taken to validate computer systems at your institution
Presented By
James Riddle
MCSE, CIP, CPIA, CRQM
VP of Research Services & Strategic Consulting
Advarra
Stuart Cotter
Director of Product Management
Advarra
Shannon Roznoski
Director of Product Management
Advarra
NA
NA
NA
NA
DATE: July 8, 2020
Time: 1 pm ET | 10 am PT
Duration: 1 hour